Advances in CDK4 and 6 Inhibitors: Transforming Breast Cancer Treatment. [PDF]
Santander Ballestín S+5 more
europepmc +1 more source
Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer. [PDF]
Esquer H, Zhou Q, LaBarbera DV.
europepmc +1 more source
Targeting CDK4/6 in breast cancer. [PDF]
Shanabag A, Armand J, Son E, Yang HW.
europepmc +1 more source
Prognostic Evaluation and Functional Characterization of Cyclin K Expression in Endometrial Cancer: Immunohistochemical and In Silico Analysis. [PDF]
Szymański M+4 more
europepmc +1 more source
Estimation and model selection for finite mixtures of Tukey's <i>g</i>- &-<i>h</i> distributions. [PDF]
Zhan T+4 more
europepmc +1 more source
Circ-PAN3 facilitates hepatocellular carcinoma growth via sponging miR-153 and upregulating cyclin D1. [PDF]
Yu S, Wang M, Li XU, Guo X, Qin R.
europepmc +1 more source
A phosphate-binding pocket in cyclin B3 is essential for XErp1/Emi2 degradation in meiosis I. [PDF]
Schunk R+6 more
europepmc +1 more source
Schisandrin B targets CDK4/6 to suppress proliferation and enhance radiosensitivity in nasopharyngeal carcinoma by inducing cell cycle arrest. [PDF]
Fang Y+7 more
europepmc +1 more source